about
50 years of hurdles and hope in anxiolytic drug discoveryThe age of anxiety: role of animal models of anxiolytic action in drug discovery.Apolipoprotein E-low density lipoprotein receptor interaction affects spatial memory retention and brain ApoE levels in an isoform-dependent manner.Apolipoprotein E isoform-dependent effects on anxiety and cognition in female TR mice.Progressive loss of synaptic integrity in human apolipoprotein E4 targeted replacement mice and attenuation by apolipoprotein E2.Altered neurotransmission in the lateral amygdala in aged human apoE4 targeted replacement mice.CNF1 increases brain energy level, counteracts neuroinflammatory markers and rescues cognitive deficits in a murine model of Alzheimer's disease.Neuropsychiatric Symptoms, Endophenotypes, and Syndromes in Late-Onset Alzheimer's Disease: Focus on APOE Gene.DNA methylation and single nucleotide variants in the brain-derived neurotrophic factor (BDNF) and oxytocin receptor (OXTR) genes are associated with anxiety/depression in older women.ApoE2 Exaggerates PTSD-Related Behavioral, Cognitive, and Neuroendocrine Alterations.Moderating risk of Alzheimer's disease through the use of anxiolytic agents.Genotype differences in anxiety and fear learning and memory of WT and ApoE4 mice associated with enhanced generation of hippocampal reactive oxygen species.Vascular pathology of 20-month-old hypercholesterolemia mice in comparison to triple-transgenic and APPSwDI Alzheimer's disease mouse models.Paradoxical effects of 137Cs irradiation on pharmacological stimulation of reactive oxygen species in hippocampal slices from apoE2 and apoE4 mice.Upregulation of Mineralocorticoid Receptor in the Hypothalamus Associated with a High Anxiety-like Level in Apolipoprotein E4 Transgenic Mice.
P2860
Q28297569-FA342C43-1DCB-45AC-A05E-64AEBDE1B2F2Q30462832-68919A2A-3911-4C5D-9941-A8156036BD87Q30572801-ACC8A35D-5D4D-4734-B155-1839851CF5D2Q34110834-25406DF5-2042-46C6-8503-143680A0DF63Q34348323-F80648BD-E890-481E-921A-71DE08815AFBQ34593131-97871FAE-02EA-44EB-9CDC-5D84EAB37698Q34759070-FFE0FA1D-A291-4AD8-BFCD-652FEE68488EQ34953672-E91A1297-7296-4E7E-9D37-836806264FF6Q35796396-18944D33-4229-4C09-B251-3E0E1282017EQ35960386-9E6E8EAC-8E87-4A0E-B9E8-2B3BEF69081EQ39224343-F82B8E05-42DA-4401-B057-5585E2EB6E56Q41057697-77C26E84-D22B-47E8-BE40-7692372AD996Q41757936-BFBCE26F-9893-4498-AF44-DA9A46C5B510Q46269349-FBADE7A4-32BB-42C0-B9EF-A667EB8AAEBCQ48247745-943ACDD5-CA51-4C68-AA0B-480E81461B78
P2860
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Role of apolipoprotein E in anxiety
@ast
Role of apolipoprotein E in anxiety
@en
Role of apolipoprotein E in anxiety
@nl
type
label
Role of apolipoprotein E in anxiety
@ast
Role of apolipoprotein E in anxiety
@en
Role of apolipoprotein E in anxiety
@nl
altLabel
Role of Apolipoprotein E in Anxiety
@en
prefLabel
Role of apolipoprotein E in anxiety
@ast
Role of apolipoprotein E in anxiety
@en
Role of apolipoprotein E in anxiety
@nl
P2860
P356
P1433
P1476
Role of apolipoprotein E in anxiety
@en
P2093
Jacob Raber
P2860
P356
10.1155/2007/91236
P407
P577
2007-01-01T00:00:00Z